Literature DB >> 3864531

Characterization of autostimulatory and transforming growth factors from human melanoma cells.

A Richmond, D H Lawson, D W Nixon, R K Chawla.   

Abstract

Serum-free growth of the human malignant melanoma cell line Hs0294 is associated with production of transforming growth factor-alpha and an autostimulatory melanoma mitogen (melanoma growth-stimulatory activity, MGSA). The transforming activity is characterized by stimulation of anchorage-independent growth of normal rat kidney fibroblasts and competition with 125I-epidermal growth factor for binding to normal rat kidney cells. The second activity, MGSA, stimulates the anchorage-dependent growth of human melanoma cells in serum-free culture medium. When acetic acid extracts of Hs0294 conditioned medium are subjected to Bio-Gel P-30 chromatography followed by reverse-phase high-pressure liquid chromatography, the majority of the transforming growth factor-alpha elutes at 30 +/- 4% acetonitrile, while the major peak of MGSA elutes at 35 +/- 3% acetonitrile. These data indicate that the anchorage-dependent serum-free growth of the Hs0294 human melanoma cell line is apparently dependent upon the autostimulatory melanoma mitogen, MGSA, which is separable from the 125I-epidermal growth factor competing activity produced by these cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3864531

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

Review 1.  Growth factor and growth factor receptor in radiation carcinogenesis.

Authors:  F C Leung
Journal:  Radiat Environ Biophys       Date:  1991       Impact factor: 1.925

Review 2.  Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?

Authors:  Mike Veenstra; Richard M Ransohoff
Journal:  J Neuroimmunol       Date:  2012-03-22       Impact factor: 3.478

Review 3.  CXCL8 and its cognate receptors in melanoma progression and metastasis.

Authors:  Seema Singh; Ajay P Singh; Bhawna Sharma; Laurie B Owen; Rakesh K Singh
Journal:  Future Oncol       Date:  2010-01       Impact factor: 3.404

4.  A synthetic peptide inhibitor for alpha-chemokines inhibits the growth of melanoma cell lines.

Authors:  S Hayashi; A Kurdowska; A B Cohen; M D Stevens; N Fujisawa; E J Miller
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

5.  HMGI(Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene.

Authors:  L D Wood; A A Farmer; A Richmond
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

6.  CCAAT displacement protein regulates nuclear factor-kappa beta-mediated chemokine transcription in melanoma cells.

Authors:  Yukiko Ueda; Yingjun Su; Ann Richmond
Journal:  Melanoma Res       Date:  2007-04       Impact factor: 3.599

7.  Growth control of A431 cells in protein-free medium: secretory products do not affect cell growth.

Authors:  Y Masuda; Y Yoshitake; K Nishikawa
Journal:  In Vitro Cell Dev Biol       Date:  1988-09

Review 8.  Growth factors in melanoma.

Authors:  U Rodeck; M Herlyn
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

9.  BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways.

Authors:  Jinming Yang; Katayoun I Amiri; James R Burke; Johannes A Schmid; Ann Richmond
Journal:  Clin Cancer Res       Date:  2006-02-01       Impact factor: 12.531

Review 10.  NF-kappaB activation in melanoma.

Authors:  Yukiko Ueda; Ann Richmond
Journal:  Pigment Cell Res       Date:  2006-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.